ACI
NVO

AMP Capital Investors’s Novo Nordisk NVO Stock Holding History

AMP Capital Investors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-102,410
Closed -$3.36M – 1288
2020
Q2 		$3.36M Sell
102,410
-34,376
-25% -$1.1M 0.02% 607
2020
Q1 		$4.12M Sell
136,786
-67,194
-33% -$2M 0.03% 503
2019
Q4 		$5.89M Buy
203,980
+106,772
+110% +$2.96M 0.03% 522
2019
Q3 		$2.51M Hold
97,208
– – 0.01% 706
2019
Q2 		$2.47M Sell
97,208
-167,600
-63% -$4.14M 0.01% 702
2019
Q1 		$6.89M Hold
264,808
– – 0.04% 457
2018
Q4 		$6.07M Buy
264,808
+139,856
+112% +$3.11M 0.04% 455
2018
Q3 		$2.98M Buy
124,952
+98,422
+371% +$2.4M 0.02% 674
2018
Q2 		$612K Buy
+26,530
New +$631K ﹤0.01% 962
2018
Q1 		– Sell
-36,104
Closed -$969K – 1200
2017
Q4 		$969K Buy
+36,104
New +$918K 0.01% 910
2016
Q2 		– Sell
-170,232
Closed -$4.62M – 1224
2016
Q1 		$4.62M Sell
170,232
-49,278
-22% -$1.32M 0.03% 508
2015
Q4 		$6.45M Buy
219,510
+50,100
+30% +$1.39M 0.04% 424
2015
Q3 		$4.53M Buy
169,410
+98,302
+138% +$2.78M 0.03% 475
2015
Q2 		$1.94M Buy
71,108
+28,098
+65% +$790K 0.01% 731
2015
Q1 		$1.18M Sell
43,010
-171,804
-80% -$3.96M 0.01% 856
2014
Q4 		$4.58M Sell
214,814
-10,416
-5% -$233K 0.03% 521
2014
Q3 		$5.45M Buy
225,230
+68,140
+43% +$1.57M 0.03% 475
2014
Q2 		$3.61M Buy
+157,090
New +$3.47M 0.02% 606
2013
Q3 		– Sell
-81,220
Closed -$1.28M – 1261
2013
Q2 		$1.28M Buy
+81,220
New +$1.35M 0.01% 838

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

AMP Capital Investors's NVO Position: Q3 2020 in Review

AMP Capital Investors sold out of Novo Nordisk (NVO) in Q3 2020, closing a stake of 102,410 shares — an estimated $3.36M sold.

AMP Capital Investors first reported a position in NVO in Q2 2013 and held it in 19 quarters. The position peaked at $6.89M in Q1 2019. 659 funds tracked by Wall St. Rank hold NVO as of Q3 2020.

  • AMP Capital Investors reported no remaining Novo Nordisk position as of Q3 2020 after selling out during the quarter.
  • AMP Capital Investors sold 102,410 Novo Nordisk shares in Q3 2020, an estimated $3.36M.
  • AMP Capital Investors first reported a position in Novo Nordisk in Q2 2013 and held it in 19 quarters.
  • AMP Capital Investors's Novo Nordisk position peaked at $6.89M in Q1 2019.
  • 659 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2020.

Based on AMP Capital Investors's 13F filing for Q3 2020, filed 12 Nov 2020.